GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

RIGL · Mar 31, 2026

RIGEL PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001034842-26-000032General Corporate

Debt relative to revenue44thOwn-history percentile · N=9

Evidence method

Level · gp.fundamentals.debt_to_revenue

76.51% · OPTIONAL · VALID

Operating cash generation44thOwn-history percentile · N=9

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

4.63% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

10.28% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure78thOwn-history percentile · N=9

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

19.81% · OPTIONAL · VALID

Operating margin44thOwn-history percentile · N=9

Evidence method

Level · gp.fundamentals.operating_margin

20.21% · CORE · VALID

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

19.85% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensity44thOwn-history percentile · N=9

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

5.88% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History7 statesHistory building

Dec 31, 20240/6 normalizedLevel 3 Mar 31, 20250/6 normalizedLevel 3 Jun 30, 20250/6 normalizedLevel 3 Sep 30, 20250/6 normalizedLevel 3 Dec 31, 20255/7 normalizedLevel 3 Mar 31, 20265/7 normalizedLevel 3 Jun 30, 20264/6 normalizedLevel 3

Period transition

What moved in the state?

Balance Sheet Leverage Increased

Previous: 17.84%
Current: 76.51%
Delta: 58.67%

Cash Generation Decreased

Previous: 25.71%
Current: 4.63%
Delta: -21.08%

Growth Decreased

Previous: 64.15%
Current: 10.28%
Delta: -53.86%

Inventory Pressure Increased

Previous: 3.91%
Current: 19.81%
Delta: 15.90%

Profitability Decreased

Previous: 42.63%
Current: 20.21%
Delta: -22.43%

R And D Intensity Increased

Previous: 11.31%
Current: 19.85%
Delta: 8.54%

Sbc Intensity Increased

Previous: 4.32%
Current: 5.88%
Delta: 1.56%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · RIGL Fundamental State →Transitioned To · RIGL BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · RIGL CASH_GENERATION_DECREASED →Transitioned To · RIGL GROWTH_DECREASED →Transitioned To · RIGL INVENTORY_PRESSURE_INCREASED →Transitioned To · RIGL PROFITABILITY_DECREASED →Transitioned To · RIGL R_AND_D_INTENSITY_INCREASED →Transitioned To · RIGL SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.